Capital Fund Management (CFM)
ANIP icon

Capital Fund Management (CFM)’s ANI Pharmaceuticals ANIP Stock Holding History

Capital Fund Management (CFM)’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-6,345
Closed -$391K – 1545
2019
Q4 		$391K Buy
+6,345
New +$420K 0.01% 1494
2018
Q3 		– Sell
-10,100
Closed -$675K – 1942
2018
Q2 		$675K Buy
10,100
+5,100
+102% +$318K 0.01% 1480
2018
Q1 		$291K Buy
+5,000
New +$317K ﹤0.01% 1645
2015
Q1 		– Sell
-6,400
Closed -$361K – 1423
2014
Q4 		$361K Buy
+6,400
New +$282K 0.01% 1267

Other funds holding ANIP

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return